DIONNE WALLACE: Open Payments
NPI 1417456989 · MAUMELLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 14 payments from 9 companies in 2025. Trend: 2023 $87 · 2024 $114 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 3 | $259 |
| Paratek Pharmaceuticals, Inc. | 3 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $133 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $93 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: VOQUEZNA, NUZYRA, CAPLYTA, Kerendia, GVOKE HYPOPEN, MOUNJARO, Cologuard Collection Kit, SHINGRIX.
Industry payments across AR — which companies pay providers there.
